Aurélien Lambert

20PUBLICATIONS
81CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAutonomous agents and multiagent systemsMolecular targetsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 03, 2026
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.

|Jul 27, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

|Apr 14, 2026
Beyond Mankind, Self-Illusion and Medical Expertise of Artificial Intelligence in the Era of COVID-19.

Arthur Claessens, Yann-Erick Claessens, Aurélien Lambert

|Feb 23, 2026
AI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative Study.

Arthur Claessens, Alizée Simon, Agathe Manchart

|Jan 28, 2026
Sarcopenia Predicts Mortality in Bladder Cancer with Neoadjuvant Chemotherapy: A Multicenter Study.

Alice Pitout, Charles Mazeaud, Alicia Blondeau

|Jun 30, 2025
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.

Edith Borcoman, Bastien Cabarrou, Miguel Francisco

Pageof 4

Frequent Collaborators

9 joint publications

Thierry Conroy

5 joint publications

Julia Salleron

4 joint publications

Alexandre Harlé

4 joint publications

Jean-Luc Raoul